Suchergebnisse - "Ring, Alistair"

PubPharm (166)

1

Late cardiotoxicity related to HER2-targeted cancer therapy

enthalten in: Cardio-oncology (London, England) | 2024

von Senechal, I. | Andres, M. | Tong, J. | +7

2

Late cardiotoxicity related to HER2-targeted cancer therapy

enthalten in: Cardio-Oncology | 2024

von Senechal, I. | Andres, M. | Tong, J. | +7

3

Implementation of a geriatric oncology service at the Royal Marsden Hospital

enthalten in: Journal of geriatric oncology | 2024

von Mac Eochagain, C. | Barrell, A. | Slavova-Boneva, V. | +10

4

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer

enthalten in: Cancer discovery | 2024

von Kingston, B. | Pearson, A. | Herrera-Abreu, M. | +14

5

"What matters to you?" Patient-reported treatment goals in geriatric oncology : A cross-sectional survey

enthalten in: Journal of geriatric oncology | 2024

von Mac Eochagain, C. | Barrell, A. | Murphy, J. | +6

6

Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

enthalten in: Drugs - real world outcomes | 2023

von Ring, A. | Karuturi, M. | Smyth, E. | +8

7

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer : Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Ring, A. | Kilburn, L. | Pearson, A. | +21

8

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Pfeiler, G. | Hlauschek, D. | Mayer, E. | +49

9

Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

enthalten in: Drugs - real world outcomes | 2023

von Ring, A. | Karuturi, M. | Smyth, E. | +8

10

Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

enthalten in: Advances in therapy | 2023

von Ring, A. | Karuturi, M. | Smyth, E. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]